Central line present
|
32 (97)
|
60 (94)
|
1.41 (0.19- 10.0)
|
-
|
[0.73]
|
Central line duration (days)
|
15.5 (2–37)
|
14 (2–56)
|
[0.46]
|
-
|
Not on enteral feeds
|
8 (24%)
|
4 (6%)
|
4.28 (1.08-16.54)
|
-
|
[0.04]
|
Duration intravenous lipid (days)
|
16 (7–69)
|
15 (1–35)
|
[0.09]
|
1.25 (1.01-1.56)
|
[0.0.049]
|
Duration intravenous amino acid (days)
|
16 (3–70)
|
16 (6–38)
|
0.12
|
-
|
NEC preceding IC
b
|
12 (35)
|
6 (10)
|
7.04 (1.50-33.30)
|
4.81 (1.14-20.41)
|
[0.01]
|
[0.03]
|
Bacterial infection including UTI
|
17 (50)
|
19 (31)
|
2.26 (0.96-5.36)
|
2.79 (0.57-13.68)
|
[0.10]
|
[0.21]
|
Any antifungal therapy prior to IC onset
|
13 (35)
|
10 (17)
|
2.21 (0.71-6.85)
|
-
|
[0.17]
|
Prior GI surgery
|
2 (6)
|
2 (3)
|
2.59 (0.03-33.00)
|
-
|
[0.43]
|
H
2
blocker
|
9 (27)
|
7 (11)
|
2.94 (0.96-9.09)
|
0.67 (0.13-3.46)
|
[0.06]
|
[0.63]
|
Steroids
|
10 (29)
|
13 (21)
|
1.25 (0.34-4.57)
|
-
|
[0.74]
|
Theophylline
|
3 (9)
|
3 (5)
|
1.56 (0.24-10.56)
| |
[0.64]
|
Intubation (median days)
|
10 (1–71)
|
9.5 (1–31)
|
0.67
|
-
|
Broad spectrum antibiotics
|
26 (76)
|
37 (60)
|
1.06 (0.97-1.15)
| |
| | |
0.20
| |